In their recent meeting, New Mexico officials took a step toward adding female orgasmic disorder (FOD) to the list of conditions eligible for medical marijuana.
The state’s Medical Cannabis Advisory Board voted 7 to 2 this week to recommend the inclusion of FOD in the state’s medical marijuana program. The board’s recommendation will now be reviewed by the health secretary, who will assess the proposal and consult with staff before making a final decision to approve, reject, or modify it.
According to a study published in May in the journal Sexual Medicine, marijuana significantly improves the sexual experiences of women facing orgasmic disorders.
“Among participants who experienced challenges in achieving orgasm, 72.8% reported that cannabis use before partnered sex increased orgasm frequency, 67% stated that it improved orgasm satisfaction, and 71% indicated that cannabis use made orgasm easier”, states the study. “The frequency of cannabis use before partnered sex correlated with increased orgasm frequency for women who experienced difficulties achieving orgasm. The reasons for cannabis use before partnered sex resulted in a more positive orgasm response.”
Although marijuana is legal for recreational use in New Mexico, the state’s medical marijuana law is still relevant as patients can purchase marijuana tax free, and they can possess more at any given time.
In June, Connecticut’s Medical Marijuana Program Board of Physicians voted to add both female orgasmic disorder (FOD) and autism spectrum disorder (ASD) as qualifying medical marijuana conditions.
